Nature of Operations and Basis of Presentation (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aug. 19, 2019 |
Apr. 11, 2019 |
Jan. 24, 2019 |
Dec. 17, 2018 |
Nov. 14, 2018 |
Sep. 30, 2019 |
Jun. 30, 2019 |
Mar. 31, 2019 |
Sep. 30, 2018 |
Jun. 30, 2018 |
Mar. 31, 2018 |
Sep. 30, 2019 |
Sep. 30, 2018 |
Dec. 31, 2018 |
|
| Common stock, par value | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001 | |||||||||
| Gross proceeds of warrant | $ 575,000 | |||||||||||||
| Anti-dilution shares embedded | 20,492,303 | 937,734 | 15,591,192 | 842,767 | ||||||||||
| Proceeds from promissory note | $ 4,515,000 | $ 752,579 | ||||||||||||
| Proceeds from note receivable | 4,515,000 | |||||||||||||
| Accumulated deficit | $ (41,294,108) | (41,294,108) | $ (39,112,401) | |||||||||||
| Net loss | $ (2,689,342) | $ 7,422 | $ 500,213 | $ (3,008,675) | $ (2,716,255) | $ (1,412,686) | (2,181,707) | (7,137,615) | ||||||
| Net cash used in operating activities | $ (8,433,420) | $ (1,713,764) | ||||||||||||
| Investor [Member] | ||||||||||||||
| Warrants price per share | $ 1.00 | |||||||||||||
| Investor [Member] | Series A Note [Member] | ||||||||||||||
| Debt instrument face amount | $ 6,720,000 | |||||||||||||
| Payment of promissory note | $ 5,000,000 | |||||||||||||
| Investor [Member] | Notes [Member] | ||||||||||||||
| Percentage for original issue discount | 15.00% | |||||||||||||
| Debt instrument face amount | $ 4,780,000 | |||||||||||||
| Investors [Member] | Series C Convertible Preferred Stock [Member] | ||||||||||||||
| Conversion of common stock | 4,268,000 | |||||||||||||
| Conversion of stock, description | The shares of Series C Convertible Preferred Stock are convertible into 4,268,000 shares of the Company's common stock, and rights to convert into common stock are subject to limitations on ownership at any one time of Company common stock up to 9.9% of the issued and outstanding shares of common stock of the Company; otherwise, the Series C Convertible Preferred Stock has no rights not awarded to holders of common stock of the Company. | |||||||||||||
| Securities Purchase Agreement [Member] | Institutional Investor [Member] | ||||||||||||||
| Proceeds from promissory note | $ 11,500,000 | |||||||||||||
| Percentage for original issue discount | 15.00% | |||||||||||||
| Description for market capitalization | The Investor Note is subject to optional prepayment at any time at the option of the investor and mandatory prepayment, at the Company's option, subject to certain equity conditions, at any time 45 Trading Days after the effectiveness of a resale registration statement (or otherwise the applicability of Rule 144 promulgated under the Securities Act of 1933, as amended). Notwithstanding the foregoing, the Company may not effect a mandatory prepayment if the shares underlying the Series A Note and the portion of the Series B Note that has become unrestricted exceeds 35% of the market capitalization of the Company. | |||||||||||||
| Over-Allotment Option [Member] | Underwriting Agreement [Member] | ||||||||||||||
| Common stock, par value | $ 0.0001 | |||||||||||||
| Option to purchase shares of common stock | 25,000 | |||||||||||||
| Exercise price per share | $ 4.98 | |||||||||||||
| Proceeds from over allotment options | $ 121,909 | |||||||||||||
| Commission and expenses | $ 10,601 | |||||||||||||
| Class A Units [Member] | IPO [Member] | ||||||||||||||
| Initial public offering, shares | 2,670,000 | |||||||||||||
| Common stock, par value | $ 0.0001 | |||||||||||||
| Warrants price per share | $ 5.00 | |||||||||||||
| Proceeds from initial public offering | $ 12,415,500 | |||||||||||||
| Underwriting discounts and commission | 934,500 | |||||||||||||
| Stock issuance cost | $ 743,765 | |||||||||||||
| Series A Warrant [Member] | ||||||||||||||
| Warrants to purchase common stock | 1 | |||||||||||||
| Series B Warrant [Member] | ||||||||||||||
| Warrants to purchase common stock | 1 | |||||||||||||
| Conversion of common stock | 832,623 | 4,988,923 | ||||||||||||
| Series A Warrants [Member] | Investors [Member] | ||||||||||||||
| Warrants to purchase common stock | 1,189,560 | 508,940 | ||||||||||||
| Conversion of common stock | 508,940 | |||||||||||||
| Series A Warrants [Member] | Underwriting Agreement [Member] | ||||||||||||||
| Warrants to purchase common stock | 400,500 | |||||||||||||
| Warrants price per share | $ 0.01 | |||||||||||||
| Series A Warrants [Member] | Exchange Agreements [Member] | ||||||||||||||
| Warrants to purchase common stock | 424,116 | |||||||||||||
| Stock issuance cost | $ 159,958 | |||||||||||||
| Gross proceeds of warrant | $ 2,172,680 | |||||||||||||
| Series B Warrants [Member] | Investors [Member] | ||||||||||||||
| Warrants to purchase common stock | 1,005,760 | |||||||||||||
| Anti-dilution shares embedded | 4,268 | |||||||||||||
| Series B Warrants [Member] | Underwriting Agreement [Member] | ||||||||||||||
| Warrants to purchase common stock | 400,500 | |||||||||||||
| Warrants price per share | $ 0.01 | |||||||||||||
| New Warrants [Member] | Investors [Member] | ||||||||||||||
| Warrants to purchase common stock | 933,056 | |||||||||||||
| Warrants price per share | $ 3.67 | |||||||||||||